Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA
|
|
- Gwen Miles
- 5 years ago
- Views:
Transcription
1 Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA 2010 Vertex Pharmaceuticals Incorporated
2 Outline Introduction: Traceability in ADaM Programming Introduction: SRCDOM, SRCVAR, and SRCSEQ Triplet Establishing Traceability in Sweat Chloride Analysis Dataset (ADSW) Using SRC Triplet Conclusion Questions/Comments/Thoughts 2
3 The Key Principles Of ADaM as Stated in ADaM IG v Analysis data should be analysis ready 2. Provide a level of traceability back to the input data 3
4 Introduction: What is Traceability? Per ADaM IG V1.0, The Property That Enables The Understanding Of Data Linkage And/Or the Relationship Between An Element And Its Predecessor (s) Two Levels Of Traceability 1. Metadata Traceability 2. Data Point Traceability 2010 Vertex Pharmaceuticals Incorporated
5 Metadata? Metadata: The Information About Data ADaM Programming Specification and Define.xml Provides Meta Data Traceability. 1. Programming Specification 2. Define.xml 2010 Vertex Pharmaceuticals Incorporated
6 Introduction: Data Point Traceability Enables the Users to Go Directly to the Specific Predecessor (s) Should Be Implemented If Practically Feasible Can Be Very Useful When A Reviewer Is Trying to Trace a Complex Manipulation Path Is Established by Providing Clear Links in the Data to the Data Specific Value Used As Input For Analysis Value May Not Always Practical or Feasible to Provide Data-point Traceability Via Record-identifier Variables From Source Dataset (s) 2010 Vertex Pharmaceuticals Incorporated
7 How To Build Data Point Traceability? (I) ADaM IG V1.0 recommends numerous ways to build Data Point Traceability. Few Examples: 1. Inclusion of a supportive row or column for traceability even if not required for analysis (VISIT, --SEQ.) 2. PARAMTYP= DERIVED 3. Populating variable DTYPE with derivation method 7
8 How To Build Data Point Traceability? (II) 4. Populating ANLxxFL to support the accurate selection of records for analysis 5. CRITy/CRITyFL/CRITyFN variables to define and detect the presence of a criterion 6. Combine the Triplet of SRCDOM, SRCVAR, and SRCSEQ with Derived Variables in ADaM IG 1.0 in Page 38 8
9 Goal to Build Traceability in ADaM Data 1. Facilitate Transparency 2. Build Confidence in Analysis Results 3. Facilitate Programming Validation 4. Speed Up the Overall Review Process from FDA Reviewers 5. Build A Good Relationship with FDA Reviewers Vertex Pharmaceuticals Incorporated
10 Definition: Using Triplet: SRCDOM, SRCVAR, and SRCSEQ to Build Traceability (I) SRCDOM Source Domain The 2-character identifier of the SDTM domain that relates to AVAL or AVALC. SRCVAR Source Variable The name of the column (in the SDTM domain identified by SRCDOM) that relates to AVAL or AVALC. SRCSEQ Source Sequence Number The sequence number SEQ of the row (in the SDTM domain identified by SRCDOM) that relates to AVAL or AVALC Vertex Pharmaceuticals Incorporated
11 Definition: Using Triplet: SRCDOM, SRCVAR, and SRCSEQ to Build Traceability (II) Per the definition from ADaM IG V SRCDOM should be a SDTM domain. 2. SRCVAR should be a variable from SDTM domain. 3. SRCSEQ should be a SEQ from SDTM domain. 11
12 Limitation Of SRCDOM, SRCVAR, and SRCSEQ Limitation of the Triplet : One Source SDTM Domain One Source Record One Source Variable Only Direct Copy of Source Value Can NOT Keep Traceability When An Analysis Parameter in ADaM Is Derived from Multiple SDTM Records. 12
13 Solutions to the Limitation This presentation provides examples of using SRC--- triplet to resolve this limitation by slightly modifying the usage of SRC--- triplet without losing the actual definition. Use Another Method Shown in the Next Slide 13
14 Another Method: Adding Variable Pair : RLCRIT and RLFACT Use Metadata to Describe the Derivation Rules of the Derived Parameters Add Variables RLCRIT and RLFACT to Connect Derived Records and Their Source Records: RLCRIT - relation criteria that stores data source (ADaM or SDTM data sets) with source variables in order RLFACT - relation factors that stores the values of those source variables in the same order Refer to 1. Zhu, Songhui and Yan, Lin. Methods of Building Traceability for ADaM Data. PharmaSUG Xiangchen (Bob) Cui, Hongyu Liu, and Tathabbai Pakalapati. Examples of Building Traceability in CDISC ADaM Datasets for FDA Submission. SAS Global, April Vertex Pharmaceuticals Incorporated
15 Introduction In this presentation, the examples were from efficacy ADaM datasets from Cystic Fibrosis therapeutic area. We will discuss ADSW (Sweat Chloride Analysis Data Set) today. 15
16 Structure of Sweat Chloride of SDTM.SW Note: Records with even numbers of swseq were from the volume and the records with odd numbers of swseq were used for analysis. 16
17 Analysis Value of Sweat Chloride (ADSW.AVAL) at An Analysis Visit (AVISIT) in ADaM Per SAP 1. Analysis Value at Each Analysis Visit (AVISIT): Average of Sweat Chloride at Both Left and Right Arms Collected at A Nominal Visit 2. Baseline Analysis Visit: Average of Sweat Chloride from the Pre-dose Scheduled Visits 3. Average On-treatment Sweat Chloride: Average of Sweat Chloride from the On-treatment Scheduled Visits Note: 2 and 3 are the Average of analysis values from 1, i.e. values from ADaM.ADSW, not SDTM.SW. 17
18 Building Data Point Traceability for These Three Averages in ADSW Create Variable ASWSEQ= Analysis Sequence Number Starting from 1000 to Indicate the Newly Created Records PARAMTYP= DERIVED DTYPE= AVERAGE Populate the Variable SRCDOM, SRCVAR, and SRCSEQ to These Newly Created Records 18
19 Traceability For Average Sweat Chloride At Both Left And Right Arms At Every Analysis Visit 1. PARAMTYP= DERIVED tells the reviewer these records are derived in ADaM, with sequence numbers above SRCSEQ=23 for AVISIT= Day 14 suggests that only sweat chloride at left arm is used to populate AVAL, as sweat chloride at right arm is missing SRCSEQ lists sequence numbers, separated by $, of those records in SDTM SW used in deriving AVAL. Hence SRCSEQ is the concatenation of two sequence numbers--- A deviation from IG!
20 Traceability For Baseline Analysis Visit (I) ASWSEQ = 0.5 more than the sequence number corresponding to the last predose analysis visit ( ) to be created as a new sorting key in ADSW SRCDOM= ADSW, SRCVAR= AVAL and SRCSEQ= 1001$1002 for AVISIT= Baseline indicating that analysis value (AVAL) is derived, using the AVAL in ADSW, corresponding to sequence numbers 1001 and 1002 (Screening and Day 1 visit, respectively). SRC-triplet above shows another deviation from ADaM IG! 20
21 Traceability For Average On-Treatment Sweat Chloride Defined as the average of on-treatment analysis values (Day 7, 14, 21, and 28) Its calculation is same as one from Baseline Analysis Visit for traceability with SRCDOM=ADSW and SRCVAR=AVAL. 21
22 An Example of Traceability For Average On- Treatment Sweat Chloride (I) 22
23 An Example of Traceability For Average On- Treatment Sweat Chloride (II) How About We Change SRCSEQ= 1005$1006$1007$1008 into More Meaningful SRCSEQ= DAY 7$DAY 14$DAY 21$DAY 28? Better communication and reviewing of the data records 23
24 An Example of Traceability For Average On- Treatment Sweat Chloride (III) SRCSEQ= DAY 7$DAY 14$DAY 21$DAY 28 SRCSEQ is from VISIT, not ASWSEQ anymore! No sequence numbers are involved! A severe deviation from ADaM IG! 24
25 An Example of Traceability For Average On- Treatment Sweat Chloride (III) 25
26 An Example of Traceability For Average On- Treatment Sweat Chloride (I) 26
27 Snapshot of Traceability For Average On-Treatment Sweat Chloride for Multiple Subjects (I) 27
28 How Much To Pay For Traceability? No Free Lunch! Write A Clear ADaM Programming Specification Extra SAS Codes 2010 Vertex Pharmaceuticals Incorporated
29 Write A Clear ADaM Programming Specification Variable Name Variable Label Type Length Controlled Terms or Formats Origin Role Comments Core SRCDOM Source Domain Char 4 Derived Analysis Equal to "ADSW" for derived records (PARAMTYP="DERIVED") and AVISIT is equal to "Baseline" or "Average through Day 28" Equal to "SW" for all other derived records (PARAMTYP ="DERIVED") SRCVAR SRCSEQ Source Variable Source Sequence Number Char 8 Derived Analysis Equal to "AVAL" for derived records (PARAMTYP ="DERIVED") where AVISIT is equal to "Baseline" Equal to "AVAL" for derived records (PARAMTYP ="DERIVED") where AVISIT is equal to "Average through Day 28" Equal to "SWSTRESN" for all other derived records (PARAMTYP="DERIVED") Char 40 Derived Analysis For AVISIT="Baseline" SRCSEQ lists the sequence numbers (SW.SWSEQ) of records that are used to derive the analysis baseline value. Example: if sequence numbers of Screening and Day 1 are 1 and 2 respectively, then SRCSEQ is equal to 1$2 For AVISIT="Average through Day 28" SRCSEQ lists the analysis visits (ADSW.AVISIT) of records that are used to derive the analysis value (average of Day 7, Day 14, Day 21, Day 28). Example: if Day 7, Day 14, Day 21, Day 28 are used to drive the average then SRCSEQ is equal to Day 7$Day 14$Day 21$Day 28 For other derived records SRCSEQ lists the sequence numbers (SW.SWSEQ) of records used to derive the analysis value at each analysis visit. Example: if sequence numbers of SW_CL_L and SW_CL_R at Day 7 are 4 and 5 respectively, then SRCSEQ is equal to 4$5 for AVISIT=DAY 7 Perm Perm Perm 29
30 Extra SAS Codes for Average On-Treatment: Highlighted in Red Color *** calculate average day 1 through day 28 ( average day 7, 14, 21, and 28 by nominal visit regardless on safety follow up records; proc sort data = sw_cl_m2 out=for_avg; by usubjid swtestcd ADTM visitnum swseq; where visit in ('DAY 7','DAY 14','DAY 21') or (visit='day 28' and SWTPTNUM<=0); run; data average; length DTYPE $20. SRCSEQ $40. SRCDOM $4. SRCVAR $8.; retain total nobs 0 SRCSEQ ''; set for_avg(drop=srcseq); by usubjid SWTESTCD ADTM visitnum; if first.swtestcd then do; total=swstresn; nobs=1; SRCSEQ=strip(visit);end; else do;total=total+swstresn; nobs=nobs+1; SRCSEQ=strip(SRCSEQ) "$" strip(visit); end; if last.swtestcd then do; DTYPE='AVERAGE'; SWSTRESN=total/nobs; SWSEQ=SWSEQ+0.5; SRCDOM='ADSW'; SRCVAR='AVAL'; output; end; run; 30
31 Is it legal? Is it CDISC ADaM compliant? CDISC ADaM Validation Checks Version 1.2 Rule 180 out of 243 Rules: Only SRCDOM It is illegal! 31
32 Will We Get Caught Out! We uploaded All ADaM datasets from the study into OpenCDISC Validator for Compliance Checking. No Errors or Warning Messages Reported for SRC-triplet! 32
33 Will We Get Caught Out! Cont ed OpenCDISC Validator implements total 130 rules from CDISC ADaM Validation Checks Version 1.2 with total 243 rules. OpenCDISC Validator Website: The following is a listing of CDISC ADaM version 1.0 validation rules implemented in OpenCDISC Validator. The rules are based on the validation checks published by CDISC ADaM team. 33
34 Snapshot of OpenCDISC Validator ADaM Validation Rules from Its Web Site 34
35 Is it legal? Cont ed Rule 180 Has NOT Been Applied in OpenCDISC Validator Yet. OpenCDISC Validator Can Not Catch It! It seems that we are lucky. 35
36 The Key Message Here: Should the rule 180 be relaxed into the inclusion of a ADaM domain, in addition to single SDTM domain? Should CDISC ADaM Team Consider to Modify the Rule for SRC-Triplet? 1. SRCDOM: both a SDTM domain and a ADaM domain 2. SRCVAR: both a SDTM Variable and a ADaM Variable 3. SRCSEQ: single SDTM sequence number, multiple SDTM sequence numbers, and other variables 36
37 Conclusion Incorporating traceability features in ADaM datasets: Helps in effective program validation Speeds up the review process Transparency in submitted analysis data Good Relationship with FDA Applying SRCDOM, SRCVAR, and SRCSEQ to establish traceability is an Art, not a Rocket Science. CDISC ADaM Team Should consider to modify the rule for SRC-Triplet in order to better establishing traceability in ADaM programming! 37
38 Questions / Comments / Thoughts Vertex Pharmaceuticals Incorporated
PharmaSUG DS05
PharmaSUG 2013 - DS05 Building Traceability for End Points in Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen Cui, Vertex Pharmaceuticals Incorporated Tathabbai Pakalapati, Cytel Inc. Qunming
More informationUse of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission
PharmaSUG 2017 - Paper SS03 Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission ABSTRACT Tianshu Li, Celldex Therapeutics, Hampton, NJ Traceability is one of the
More informationTraceability Look for the source of your analysis results
Traceability Look for the source of your analysis results Herman Ament, Cromsource CDISC UG Milan 21 October 2016 Contents Introduction, history and CDISC Traceability Examples Conclusion 2 / 24 Introduction,
More informationIntroduction to ADaM and What s new in ADaM
Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis
More informationApplying ADaM Principles in Developing a Response Analysis Dataset
PharmaSUG2010 Paper CD03 Applying ADaM Principles in Developing a Response Analysis Dataset Mei Dey, Merck & Co., Inc Lisa Pyle, Merck & Co., Inc ABSTRACT The Clinical Data Interchange Standards Consortium
More informationIntroduction to ADaM standards
Introduction to ADaM standards Elke Sennewald, Director Biostatistics EU/AP, 06 March 2009 1 Outline ADaM Version 2.0 / 2.1 General Considerations ADaM draft Version 2.1 ADaMIG draft Version 1.0 ADaM Variables
More informationADaM and traceability: Chiesi experience
ADaM and traceability: Chiesi experience BIAS Seminar «Data handling and reporting in clinical trials with SAS» Glauco Cappellini 22-Feb-2013 Agenda Chiesi Model for Biometrics Regulatory Background ADaM:
More informationADaM for Medical Devices: Extending the Current ADaM Structures
PharmaSUG 2018 - Paper MD-02 ADaM for Medical s: Extending the Current ADaM Structures Sandra Minjoe, PRA Health Sciences; Julia Yang, Medtronic PLC; Priya Gopal, TESARO, Inc. ABSTRACT The current ADaM
More informationTraceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA
ABSTRACT PharmaSUG 2013 - Paper PO13 Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA Traceability is one of the fundamentals of the ADaM Standard. However, there is not
More informationPharmaSUG Paper PO22
PharmaSUG 2015 - Paper PO22 Challenges in Developing ADSL with Baseline Data Hongyu Liu, Vertex Pharmaceuticals Incorporated, Boston, MA Hang Pang, Vertex Pharmaceuticals Incorporated, Boston, MA ABSTRACT
More informationAn Efficient Solution to Efficacy ADaM Design and Implementation
PharmaSUG 2017 - Paper AD05 An Efficient Solution to Efficacy ADaM Design and Implementation Chengxin Li, Pfizer Consumer Healthcare, Madison, NJ, USA Zhongwei Zhou, Pfizer Consumer Healthcare, Madison,
More informationPharmaSUG2014 Paper DS09
PharmaSUG2014 Paper DS09 An ADaM Interim Dataset for Time-to-Event Analysis Needs Tom Santopoli, Accenture, Berwyn, PA Kim Minkalis, Accenture, Berwyn, PA Sandra Minjoe, Accenture, Berwyn, PA ABSTRACT
More informationProgramming checks: Reviewing the overall quality of the deliverables without parallel programming
PharmaSUG 2016 Paper IB04 Programming checks: Reviewing the overall quality of the deliverables without parallel programming Shailendra Phadke, Baxalta US Inc., Cambridge MA Veronika Csom, Baxalta US Inc.,
More informationRiepilogo e Spazio Q&A
Riepilogo e Spazio Q&A CDISC Italian User Network Day 27 Ottobre 2017 Angelo Tinazzi (Cytel) - Silvia Faini (CROS NT) E3C members 2 Agenda ADaM key list Bad & Good ADaM...More... Spazio Q&A ADaM Key List
More informationADaM Compliance Starts with ADaM Specifications
PharmaSUG 2017 - Paper DS16 ADaM Compliance Starts with ADaM Specifications Trevor Mankus, Kent Letourneau, PRA Health Sciences ABSTRACT As of December 17th, 2016, the FDA and PMDA require that all new
More informationHow to write ADaM specifications like a ninja.
Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation
More informationPharmaSUG Paper CC02
PharmaSUG 2012 - Paper CC02 Automatic Version Control and Track Changes of CDISC ADaM Specifications for FDA Submission Xiangchen (Bob) Cui, Vertex Pharmaceuticals, Cambridge, MA Min Chen, Vertex Pharmaceuticals,
More informationAutomate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.
Automate Analysis Results Metadata in the Define-XML v2.0 Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc., USA 1 Topics Introduction Analysis Results Metadata (ARM) Version 1.0 o o
More informationADaM Implementation Guide Prepared by the CDISC ADaM Team
1 2 3 ADaM Implementation Guide Prepared by the CDISC ADaM Team 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Revision History Notes to Readers Date Version Summary of Changes May 30, 2008 1.0 Draft
More informationPharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA
PharmaSUG 2013 - Paper DS06 Designing and Tuning ADaM Datasets Songhui ZHU, K&L Consulting Services, Fort Washington, PA ABSTRACT The developers/authors of CDISC ADaM Model and ADaM IG made enormous effort
More informationA Taste of SDTM in Real Time
A Taste of SDTM in Real Time Changhong Shi, Merck & Co., Inc., Rahway, NJ Beilei Xu, Merck & Co., Inc., Rahway, NJ ABSTRACT The Study Data Tabulation Model (SDTM) is a Clinical Data Interchange Standards
More informationLeveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets
PharmaSUG 2017 - Paper SS09 Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets Xiangchen (Bob) Cui, Min Chen, and Letan (Cleo) Lin, Alkermes Inc.,
More informationWorking with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA
PharmaSug2016- Paper HA03 Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA ABSTRACT A composite endpoint in a Randomized Clinical Trial
More informationCreating an ADaM Data Set for Correlation Analyses
PharmaSUG 2018 - Paper DS-17 ABSTRACT Creating an ADaM Data Set for Correlation Analyses Chad Melson, Experis Clinical, Cincinnati, OH The purpose of a correlation analysis is to evaluate relationships
More informationLeveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO
PharmaSUG 2015 - Paper PO13 Leveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO ABSTRACT The purpose of the CDISC Analysis Data
More informationOptimization of the traceability when applying an ADaM Parallel Conversion Method
SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method Roxane Debrus ADaM Conversion Process Agenda %LIB_QC_contents_html %adam_sdtm_compa Conclusion ADaM Conversion Process
More informationThe Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA
PharmaSUG 2017 - Paper DS23 The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA ABSTRACT Since FDA released the Analysis
More informationYes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes!
1 Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes! The ADaM documentation provides examples of many of
More informationBeyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC
Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity John Brega Linda Collins PharmaStat LLC Topics Part 1: A Standard with Many Uses Status of the Define.xml Standard
More informationADaM Implementation Guide Status Update
ADaM Implementation Guide Status Update John K. Troxell John Troxell Consulting LLC Bridgewater, NJ jktroxell@gmail.com June 17, 2013 Current CDISC ADaM Documents 2009 Analysis Data Model (ADaM), Version
More informationDoctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development
PharmaSUG 2018 - Paper DS-15 Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development Aakar Shah, Pfizer Inc; Tracy Sherman, Ephicacy Consulting Group, Inc.
More informationDealing with changing versions of SDTM and Controlled Terminology (CT)
CDISC UK Network Breakout session Notes 07/06/16 Afternoon Session 1: Dealing with changing versions of SDTM and Controlled Terminology (CT) How do people manage this? Is this managed via a sponsor Standards
More informationPharmaSUG Paper DS-24. Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP
PharmaSUG 2018 - Paper DS-24 Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP Kamlesh Patel, Rang Technologies Inc, New Jersey Jigar Patel, Rang Technologies Inc, New Jersey Dilip Patel,
More informationPharmaSUG Paper DS24
PharmaSUG 2017 - Paper DS24 ADQRS: Basic Principles for Building Questionnaire, Rating and Scale Datasets Nancy Brucken, inventiv Health, Ann Arbor, MI Karin LaPann, Shire, Lexington, MA ABSTRACT Questionnaires,
More informationTaming the SHREW. SDTM Heuristic Research and Evaluation Workshop
Taming the SHREW SDTM Heuristic Research and Evaluation Workshop September 13, 2013 Carlo Radovsky 2 Overview Introductions The Backstory CDISC IntraChange History of a Rule The Challenge Discuss Amongst
More informationOpenCDISC Validator 1.4 What s New?
OpenCDISC Validator 1.4 What s New? Bay Area CDISC Implementation Network 23 May 2013 David Borbas Sr Director, Data Management Jazz Pharmaceuticals, Inc. Disclaimers The opinions expressed in this presentation
More informationOptimization of the traceability when applying an ADaM Parallel Conversion Method
Paper SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method DEBRUS Roxane, Business & Decision Life Sciences, Brussels, Belgium ABSTRACT One of the methods to create CDISC
More informationADaM Reviewer s Guide Interpretation and Implementation
Paper CD13 ADaM Reviewer s Guide Interpretation and Implementation Steve Griffiths, GlaxoSmithKline, Stockley Park, UK ABSTRACT Throughout the course of a study, teams will make a lot of decisions about
More informationHarmonizing CDISC Data Standards across Companies: A Practical Overview with Examples
PharmaSUG 2017 - Paper DS06 Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples Keith Shusterman, Chiltern; Prathima Surabhi, AstraZeneca; Binoy Varghese, Medimmune ABSTRACT
More informationTraceability: Some Thoughts and Examples for ADaM Needs
PharmaSUG 2018 - Paper DS-01 Traceability: Some Thoughts and Examples for ADaM Needs Sandra Minjoe, PRA Health Sciences; Wayne Zhong, Accretion Softworks; Quan (Jenny) Zhou, Eli Lilly and Company; Kent
More informationDIA 11234: CDER Data Standards Common Issues Document webinar questions
Q: What is the preferred data definition format for ADaM analysis data, define.xml or define.pdf? 1 ADaM Define File Q: The CRTDDS does not describe how to submit a define.xml for ADaM. Does CDER expect
More informationNCI/CDISC or User Specified CT
NCI/CDISC or User Specified CT Q: When to specify CT? CT should be provided for every variable with a finite set of valid values (e.g., the variable AESEV in ADAE can have the values MILD, MODERATE or
More informationSandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area
Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat PharmaSUG Single Day Event San Francisco Bay Area 2015-02-10 What is the Computational Sciences Symposium? CSS originally formed to help FDA
More informationWhat is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting
Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting
More informationAn Introduction to Visit Window Challenges and Solutions
ABSTRACT Paper 125-2017 An Introduction to Visit Window Challenges and Solutions Mai Ngo, SynteractHCR In clinical trial studies, statistical programmers often face the challenge of subjects visits not
More informationFrom Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...
From Implementing CDISC Using SAS. Full book available for purchase here. Contents About This Book... xi About The Authors... xvii Acknowledgments... xix Chapter 1: Implementation Strategies... 1 Why CDISC
More informationInterpreting CDISC ADaM IG through Users Interpretation
Paper CD01 Interpreting CDISC ADaM IG through Users Interpretation Angelo Tinazzi, Cytel Inc., Geneva, Switzerland ABSTRACT It is now almost three years CDISC ADaM is an official standard the pharmaceutical
More informationIt s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0
PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges
More informationDCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on
DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on 2011-05-12 1 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical
More informationCustomer oriented CDISC implementation
Paper CD10 Customer oriented CDISC implementation Edelbert Arnold, Accovion GmbH, Eschborn, Germany Ulrike Plank, Accovion GmbH, Eschborn, Germany ABSTRACT The Clinical Data Interchange Standards Consortium
More informationAvoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation
ABSTRACT Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation Richann Watson, Experis, Batavia, OH Karl Miller, inventiv Health, Lincoln, NE The ADaM Implementation Guide was created
More informationOut-of-the-box %definexml
Out-of-the-box %definexml Just a Simple SAS Macro PhUSE / October 2016 / Katja Glaß Agenda Introduction Getting Started %DefineXML Collaborate Summary Page 2 DefineXML Katja Glaß 11. October 2016 Introduction
More informationMaterial covered in the Dec 2014 FDA Binding Guidances
Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material
More informationThe Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method
PharmaSUG 2015 - Paper AD01 The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA ABSTRACT
More informationEdwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India
Paper CD15 PhUSE 2016 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences,
More informationDeriving Rows in CDISC ADaM BDS Datasets
ABSTRACT PharmaSUG 2017 Paper DS22 Deriving Rows in CDISC ADaM BDS Datasets Sandra Minjoe, Accenture Accelerated R&D Services The ADaM Basic Data Structure (BDS) can be used for many analysis needs, including
More informationUpdates on CDISC Standards Validation
Updates on CDISC Standards Validation NJ CDISC User Group September 19, 2013 Topics CDISC standards validation initiative FDA update on SEND checks OpenCDISC v1.4.1 release OpenCDISC plans 2 CDISC validation
More informationHands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania
PharmaSUG 2013 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis
More informationMaking a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets
PharmaSUG2011 Paper CD17 Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets Elizabeth Li, PharmaStat LLC, Newark, California Linda Collins, PharmaStat
More informationSAS Application to Automate a Comprehensive Review of DEFINE and All of its Components
PharmaSUG 2017 - Paper AD19 SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components Walter Hufford, Vincent Guo, and Mijun Hu, Novartis Pharmaceuticals Corporation ABSTRACT
More informationSome Considerations When Designing ADaM Datasets
Some Considerations When Designing ADaM Datasets Italian CDISC UN Day - Milan 27 th October 2017 Antonio Valenti Principal Statistical Programmer CROS NT - Verona Content Disclaimer All content included
More informationPhUSE US Connect 2019
PhUSE US Connect 2019 Paper SI04 Creation of ADaM Define.xml v2.0 Using SAS Program and Pinnacle 21 Yan Lei, Johnson & Johnson, Spring House, PA, USA Yongjiang Xu, Johnson & Johnson, Spring House, PA,
More informationClarifications About ADaM Implementation Provided in ADaMIG Version 1.1
PharmaSUG 2017 - Paper DS18 Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1 John Troxell, Accenture ABSTRACT Since the publication of version 1.0 of the CDISC (Clinical Data Interchange
More informationesubmission - Are you really Compliant?
ABSTRACT PharmaSUG 2018 - Paper SS21 esubmission - Are you really Compliant? Majdoub Haloui, Merck & Co., Inc., Upper Gwynedd, PA, USA Suhas R. Sanjee, Merck & Co., Inc., Upper Gwynedd, PA, USA Pinnacle
More informationHow to handle different versions of SDTM & DEFINE generation in a Single Study?
Paper CD15 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai,
More informationImproving Metadata Compliance and Assessing Quality Metrics with a Standards Library
PharmaSUG 2018 - Paper SS-12 Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library Veena Nataraj, Erica Davis, Shire ABSTRACT Establishing internal Data Standards helps companies
More informationCommon Programming Errors in CDISC Data
ABSTRACT PharmaSUG 2017 - Paper DS15 Common Programming Errors in CDISC Data Sergiy Sirichenko, Pinnacle 21 Data in standardized format is now a required part of regulatory submissions. CDISC standards
More informationSDTM-ETL 3.0 User Manual and Tutorial
SDTM-ETL 3.0 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2014-03-29 Creating mappings for the SV (Subject Visits) domain Although Fred Wood, one of the authors of the SDTM Implementation
More informationLex Jansen Octagon Research Solutions, Inc.
Converting the define.xml to a Relational Database to enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D PhUSE 2009, Basel,
More informationFrom SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI
PharmaSUG2011 - Paper HW05 From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI ABSTRACT You've just read through the protocol,
More informationConsiderations on creation of SDTM datasets for extended studies
13/May/2016 As one of the activities of CDISC Japan User Group (CJUG), a small group, "Extension study team" was organized in 2015. The team discussed what kind of approach works better for SDTM creation
More informationAutomation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China
ABSTRACT Study Data Tabulation Model (SDTM) is an evolving global standard which is widely used for regulatory submissions. The automation of SDTM programming is essential to maximize the programming efficiency
More informationWhy organizations need MDR system to manage clinical metadata?
PharmaSUG 2018 - Paper SS-17 Why organizations need MDR system to manage clinical metadata? Abhinav Jain, Ephicacy Consulting Group Inc. ABSTRACT In the last decade, CDISC standards undoubtedly have transformed
More informationPharmaSUG Paper PO21
PharmaSUG 2015 - Paper PO21 Evaluating SDTM SUPP Domain For AdaM - Trash Can Or Buried Treasure Xiaopeng Li, Celerion, Lincoln, NE Yi Liu, Celerion, Lincoln, NE Chun Feng, Celerion, Lincoln, NE ABSTRACT
More informationSDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6
SDTM-ETL TM New features in version 1.6 Author: Jozef Aerts XML4Pharma July 2011 p.1/14 Table of Contents Implementation of SEND v.3.0 final...3 Automated creation of the RELREC dataset and records...4
More informationStandardizing FDA Data to Improve Success in Pediatric Drug Development
Paper RA01 Standardizing FDA Data to Improve Success in Pediatric Drug Development Case Study: Harmonizing Hypertensive Pediatric Data across Sponsors using SAS and the CDISC Model Julie Maddox, SAS Institute,
More informationStudy Data Reviewer s Guide Completion Guideline
Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on
More informationAnalysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team
Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team Notes to Readers This Implementation Guide is version 1.1 and corresponds to Version 2.1 of the
More informationImplementing CDISC Using SAS. Full book available for purchase here.
Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models
More informationWhat is high quality study metadata?
What is high quality study metadata? Sergiy Sirichenko PhUSE Annual Conference Barcelona, 2016 What is study metadata? Trial Design domains Reviewer s Guides acrf Define.xml Conclusion Topics What is study
More informationData Integrity through DEFINE.PDF and DEFINE.XML
Data Integrity through DEFINE.PDF and DEFINE.XML Sy Truong, Meta Xceed, Inc, Fremont, CA ABSTRACT One of the key questions asked in determining if an analysis dataset is valid is simply, what did you do
More informationThe application of SDTM in a disease (oncology)-oriented organization
Paper CD01 The application of SDTM in a disease (oncology)-oriented organization Angelo Tinazzi, Alessandro Cattaneo, Enrica Paschetto, Sonia Colombini SENDO-Tech S.r.l., Milan, Italy ABSTRACT Applying
More informationIntroduction to Define.xml
Introduction to Define.xml Bay Area CDISC Implementation Network 4 April 2008 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the concept and purpose of define.xml 2. Introduce the published
More informationMetadata and ADaM.
Metadata and ADaM 1 Disclaimer Any views or opinions presented in this presentation are solely those of the author and do not necessarily represent those of the company. 2 Agenda Introduction of ADaM Metadata
More informationHands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania
PharmaSUG 2014 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data
More informationSDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards
Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched
More informationProve It! Importance and Methodologies of Validation in Clinical Trials Reporting
MEDICAL WRITING CLINICAL PROGRAMMING BIOSTATISTICS DATA MANAGEMENT REGULATORY AFFAIRS MEDICAL INFORMATION Prove It! Importance and Methodologies of Validation in Clinical Trials Reporting Michigan SAS
More informationPharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes
ABSTRACT PharmaSUG 2014 PO16 Automation of ADAM set Creation with a Retrospective, Prospective and Pragmatic Process Karin LaPann, MSIS, PRA International, USA Terek Peterson, MBA, PRA International, USA
More informationDataset-XML - A New CDISC Standard
Dataset-XML - A New CDISC Standard Lex Jansen Principal Software Developer @ SAS CDISC XML Technologies Team Single Day Event CDISC Tools and Optimization September 29, 2014, Cary, NC Agenda Dataset-XML
More informationAdding, editing and managing links to external documents in define.xml
SDTM-ETL 3.1 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2015-05-25 Adding, editing and managing links to external documents in define.xml Define.xml contains the metadata of
More informationCBER STUDY DATA STANDARDS UPDATE
CBER STUDY DATA STANDARDS UPDATE Lisa Lin, MBA Study Data Standards Manager Office of the Director Center for Biologics Evaluation and Research U.S. Food & Drug Administration PhUSE US Connect Raleigh,
More informationRobust approach to create Define.xml v2.0. Vineet Jain
Robust approach to create Define.xml v2.0 Vineet Jain DEFINE SYSTEM GOALS Generic Powerful Reliable Integrable Efficient Works across SDTM, ADaM & SEND Create define.xml, annotated CRF & define.pdf Create
More informationReporting & Visualisation : D un Dun standard maison au format CDISC 02/02/2016 CDISC GUF 1
Reporting & Visualisation : D un Dun standard maison au format CDISC Jérémy MAMBRINI Florence WAGER 02/02/2016 CDISC GUF 1 Contents CDISC Implementation ti at SERVIER Reporting & Visualisation using CDISC
More informationA Practical and Efficient Approach in Generating AE (Adverse Events) Tables within a Clinical Study Environment
A Practical and Efficient Approach in Generating AE (Adverse Events) Tables within a Clinical Study Environment Abstract Jiannan Hu Vertex Pharmaceuticals, Inc. When a clinical trial is at the stage of
More informationTHE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC. PhUSE Bethan Thomas DATE PRESENTED BY
THE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC DATE PhUSE 2016 PRESENTED BY Bethan Thomas What this presentation will cover And what this presentation will not cover What is a data detective?
More informationLegacy to SDTM Conversion Workshop: Tools and Techniques
Legacy to SDTM Conversion Workshop: Tools and Techniques Mike Todd President Nth Analytics Legacy Data Old studies never die Legacy studies are often required for submissions or pharmacovigilence. Often
More informationCDISC SDTM and ADaM Real World Issues
CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC
More informationCreating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit
Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Lex Jansen Principal Software Developer @ SAS PharmaSUG 2016 Agenda Why Analysis Results Metadata?
More informationPlanning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database
PharmaSUG 2017 - Paper DS13 Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database ABSTRACT Cori Kramer, Ragini Hari, Keith Shusterman, Chiltern When SDTM
More informationCDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting
CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.
More information